Scout Bio

Developing novel vector-delivered protein therapeutics for animal health

Scout Bio is a Frazier-founded company formed to discover, develop, and commercialize protein and monoclonal antibody therapeutics expressed via one-time intra-muscular injections of adeno-associated virus (AAV) vectors for animal health. Frazier EIR Krishna Polu serves as the company’s interim CEO.

Year of Investment

2017

Strategy

Life Sciences

Subsector

Development-Stage Therapeutics

Location

Philadelphia, Pennsylvania